AI Verdict
REGN has stronger fundamentals based on our AI analysis.
REGN vs ZTS Fundamental Comparison
| Metric | REGN | ZTS |
|---|---|---|
| Revenue | $3.6B | $2.3B |
| Net Income | $727.2M | $601.0M |
| Net Margin | 20.2% | 26.6% |
| ROE | 2.3% | 18.6% |
| ROA | 1.8% | 4.0% |
| Current Ratio | 3.57x | 3.15x |
| Debt/Equity | 0.06x | 2.80x |
| EPS | $6.75 | $1.42 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
REGN vs ZTS: Frequently Asked Questions
Is REGN or ZTS the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. REGN is graded A (80% confidence) while ZTS is graded A (78% confidence). This is not investment advice.
How does REGN compare to ZTS fundamentally?
REGENERON PHARMACEUTICALS, INC. has ROE of 2.3% vs Zoetis Inc.'s 18.6%. Net margins are 20.2% vs 26.6% respectively.
Which stock pays higher dividends, REGN or ZTS?
REGN has a dividend yield of N/A or no dividend while ZTS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in REGN or ZTS for long term?
For long-term investing, consider that REGN has a A grade with 80% confidence, while ZTS has a A grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about REGN vs ZTS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs ZTS, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.